Hikal Ltd

NSE: HIKAL · BSE: 524735 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹224.24
Market cap: ₹2,765 Cr
Revenue (annual): ₹1,713 Cr
Net profit (annual): ₹-48.80 Cr
P/E (TTM): -81.8×Sector 47.4×
Promoter holding: 68.85%+0.00% QoQ
FII holding: 0.98%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Earnings Call 2 Annual General Meeting 2 Results Update 1 Production Started 1 Management Change 1 Financial Results 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

26 Aug 2026 13:18 IST BSE

Management Change

Hikal Management Change

Hikal Limited has appointed Mr. Sameer Hiremath as Chairman and Managing Director for five years. The appointment is effective from October 1, 2026, subject to shareholder approval.

Execution: 5 years

Read the filing ↗